Some studies have shown that a specific inhibitor of Smad3 can improve fibrosis and inflammation by inhibiting the TGF-β/Smad3 signaling pathway [47], but this has not been observed in studies of acne-induced PSs. This evidence concerns the gene TGFB1 and acne.